Balance Sheet Components (Tables)

6 Months Ended

Jun. 30, 2026

Balance Sheet Related Disclosures [Abstract]

Schedule of Investments in Marketable Securities

Investments in marketable securities, which are presented within current assets in the unaudited condensed consolidated balance sheets, consisted of the following (in thousands):


	June 30, 2026
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Marketable securities
U.S. treasury securities	$	185,728	$	—	$	(192)	$	185,536
Commercial paper	64,453		—		—		64,453
Corporate bonds	34,906		—		(32)		34,874

	$	285,087	$	—	$	(224)	$	284,863


	December 31, 2025
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Marketable securities
U.S. treasury securities	$	205,472	$	232	$	—	$	205,704
Commercial paper	152,792		—		—		152,792
Corporate bonds	29,672		10		—		29,682

	$	387,936	$	242	$	—	$	388,178

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities were comprised of the following (in thousands):


	June 30, 2026		December 31, 2025
Accrued salaries and employee benefits	$	25,738	$	39,301
Accrued income and other taxes payable	9,120		13,764
Accrued restructuring costs	1,215		4,215
Other accrued expenses and current liabilities	24,072		19,510
	$	60,145	$	76,790